> In a half a year the product will be across America, pharmacies,
> doctors will have it too.  The pps will go up in time but people are
> selling because they wanted a quick profit!  I'm waiting for the low
> today and buying more soon!  I have been in since Febuary so what
> another six months to a year?  We will be rewared in a yearI
> Patience!  GTLA

> In a half a year the product will be across America, pharmacies,
> doctors will have it too.  The pps will go up in time but people are
> selling because they wanted a quick profit!  I'm waiting for the low
> today and buying more soon!  I have been in since Febuary so what
> another six months to a year?  We will be rewared in a yearI
> Patience!  GTLA

> If I'd been in since February I would skim trade or take half off the
> table. Really easy to sit on a free position for the long.

> On Nov 6, 11:36 am, happy4days <happy4d...@gmail.com> wrote:

> > In a half a year the product will be across America, pharmacies,
> > doctors will have it too.  The pps will go up in time but people are
> > selling because they wanted a quick profit!  I'm waiting for the low
> > today and buying more soon!  I have been in since Febuary so what
> > another six months to a year?  We will be rewared in a yearI
> > Patience!  GTLA

> I'm with you on that Adam.  I've previously locked in profits and I'm
> now long riding on the houses money.

> On Nov 6, 10:16 am, AdamJ <ajtimper...@gmail.com> wrote:

> > If I'd been in since February I would skim trade or take half off the
> > table. Really easy to sit on a free position for the long.

> > On Nov 6, 11:36 am, happy4days <happy4d...@gmail.com> wrote:

> > > In a half a year the product will be across America, pharmacies,
> > > doctors will have it too.  The pps will go up in time but people are
> > > selling because they wanted a quick profit!  I'm waiting for the low
> > > today and buying more soon!  I have been in since Febuary so what
> > > another six months to a year?  We will be rewared in a yearI
> > > Patience!  GTLA- Hide quoted text -

> - Show quoted text -

> I know it's been discussed that Covidien buy out Nuvo after approval
> but I think with the shares trading where they are it's more likley.
> Just using some simple #'s Shares are 410M (assuming the warrants go
> through)  and in the debt of roughly 20M and cash 29M + 9M for
> warrants totaling 38M + 2M is assests brings up to around 40M + or -.
> So if Covidien put in an offer for 50 cents a share 205M + 20M (debt)
> - 40M (cash + assets) = 185M to own Nuvo. If I was Covidien I would be
> all over this, I didnt count in the 15M they just got for approval and
> if reach the goals 100M, they invested 115M they could own Nuvo for
> 70M more and would give them Pennsaid Plus and the WF10 drugs which
> would be really cheap! Most people would want the share price to be
> higher and so would I, at 75 cents a share it would cost them
> additional 172M which is still reasonable.

> These were just rough #'s but I think it's pretty sound and with out
> knowing the actual agreement it's anybodys guess. I find it a little
> suspect that the terms of the agreement still havent been released and
> they only thing I think think of is there is a buyout clause somewhere
> in it.

> Anybody else thinking the same as me on this or am I out to lunch?

> On Nov 6, 10:33 am, Rudee <rude...@gmail.com> wrote:

> > I'm with you on that Adam.  I've previously locked in profits and I'm
> > now long riding on the houses money.

> > On Nov 6, 10:16 am, AdamJ <ajtimper...@gmail.com> wrote:

> > > If I'd been in since February I would skim trade or take half off the
> > > table. Really easy to sit on a free position for the long.

> > > On Nov 6, 11:36 am, happy4days <happy4d...@gmail.com> wrote:

> > > > In a half a year the product will be across America, pharmacies,
> > > > doctors will have it too.  The pps will go up in time but people are
> > > > selling because they wanted a quick profit!  I'm waiting for the low
> > > > today and buying more soon!  I have been in since Febuary so what
> > > > another six months to a year?  We will be rewared in a yearI
> > > > Patience!  GTLA- Hide quoted text -

> > - Show quoted text -- Hide quoted text -

> - Show quoted text -

> I know it's been discussed that Covidien buy out Nuvo after approval
> but I think with the shares trading where they are it's more likley.
> Just using some simple #'s Shares are 410M (assuming the warrants go
> through)  and in the debt of roughly 20M and cash 29M + 9M for
> warrants totaling 38M + 2M is assests brings up to around 40M + or -.
> So if Covidien put in an offer for 50 cents a share 205M + 20M (debt)
> - 40M (cash + assets) = 185M to own Nuvo. If I was Covidien I would be
> all over this, I didnt count in the 15M they just got for approval and
> if reach the goals 100M, they invested 115M they could own Nuvo for
> 70M more and would give them Pennsaid Plus and the WF10 drugs which
> would be really cheap! Most people would want the share price to be
> higher and so would I, at 75 cents a share it would cost them
> additional 172M which is still reasonable.

> These were just rough #'s but I think it's pretty sound and with out
> knowing the actual agreement it's anybodys guess. I find it a little
> suspect that the terms of the agreement still havent been released and
> they only thing I think think of is there is a buyout clause somewhere
> in it.

> Anybody else thinking the same as me on this or am I out to lunch?

> On Nov 6, 10:33 am, Rudee <rude...@gmail.com> wrote:

> > I'm with you on that Adam.  I've previously locked in profits and I'm
> > now long riding on the houses money.

> > On Nov 6, 10:16 am, AdamJ <ajtimper...@gmail.com> wrote:

> > > If I'd been in since February I would skim trade or take half off the
> > > table. Really easy to sit on a free position for the long.

> > > On Nov 6, 11:36 am, happy4days <happy4d...@gmail.com> wrote:

> > > > In a half a year the product will be across America, pharmacies,
> > > > doctors will have it too.  The pps will go up in time but people are
> > > > selling because they wanted a quick profit!  I'm waiting for the low
> > > > today and buying more soon!  I have been in since Febuary so what
> > > > another six months to a year?  We will be rewared in a yearI
> > > > Patience!  GTLA- Hide quoted text -

> > - Show quoted text -

> $175 million for one product with no track record in the US? Come on
> get serious. If Covidien want to buy Nuvo it would have happened
> instead of signing a deal and throwing away $25 million. Your
> valuation of the company is based on money that the potential buyer
> has already invested which just doesn't even make sense. That type of
> deal would be a great way for the board and executives a Covidien to
> lose their jobs and face a whack of lawsuits. Chances of a buyout are
> slim to none. The main money is in the supply chain not in the
> development.

> The other reason I think why we won't see a buy out is the deal
> itself. Nuvo inked a pretty solid deal which on paper shows a non-
> royalty commitment of $125 million. The initial $25 million (agreement
> & approval bonuses) plus up to $100 million in milestone bonuses.
> Covidien could have easily bought Nuvo for that amount back in June. I
> seriously couldn't see a buyout even being considered until product
> sales total over a billion.

> On Nov 6, 2:08 pm, Medlow <med...@gmail.com> wrote:

> > I know it's been discussed that Covidien buy out Nuvo after approval
> > but I think with the shares trading where they are it's more likley.
> > Just using some simple #'s Shares are 410M (assuming the warrants go
> > through)  and in the debt of roughly 20M and cash 29M + 9M for
> > warrants totaling 38M + 2M is assests brings up to around 40M + or -.
> > So if Covidien put in an offer for 50 cents a share 205M + 20M (debt)
> > - 40M (cash + assets) = 185M to own Nuvo. If I was Covidien I would be
> > all over this, I didnt count in the 15M they just got for approval and
> > if reach the goals 100M, they invested 115M they could own Nuvo for
> > 70M more and would give them Pennsaid Plus and the WF10 drugs which
> > would be really cheap! Most people would want the share price to be
> > higher and so would I, at 75 cents a share it would cost them
> > additional 172M which is still reasonable.

> > These were just rough #'s but I think it's pretty sound and with out
> > knowing the actual agreement it's anybodys guess. I find it a little
> > suspect that the terms of the agreement still havent been released and
> > they only thing I think think of is there is a buyout clause somewhere
> > in it.

> > Anybody else thinking the same as me on this or am I out to lunch?

> > On Nov 6, 10:33 am, Rudee <rude...@gmail.com> wrote:

> > > I'm with you on that Adam.  I've previously locked in profits and I'm
> > > now long riding on the houses money.

> > > On Nov 6, 10:16 am, AdamJ <ajtimper...@gmail.com> wrote:

> > > > If I'd been in since February I would skim trade or take half off the
> > > > table. Really easy to sit on a free position for the long.

> > > > On Nov 6, 11:36 am, happy4days <happy4d...@gmail.com> wrote:

> > > > > In a half a year the product will be across America, pharmacies,
> > > > > doctors will have it too.  The pps will go up in time but people are
> > > > > selling because they wanted a quick profit!  I'm waiting for the low
> > > > > today and buying more soon!  I have been in since Febuary so what
> > > > > another six months to a year?  We will be rewared in a yearI
> > > > > Patience!  GTLA- Hide quoted text -

> > > - Show quoted text -- Hide quoted text -

> - Show quoted text -

> $175 million for one product with no track record in the US? Come on
> get serious. If Covidien want to buy Nuvo it would have happened
> instead of signing a deal and throwing away $25 million. Your
> valuation of the company is based on money that the potential buyer
> has already invested which just doesn't even make sense. That type of
> deal would be a great way for the board and executives a Covidien to
> lose their jobs and face a whack of lawsuits. Chances of a buyout are
> slim to none. The main money is in the supply chain not in the
> development.

> The other reason I think why we won't see a buy out is the deal
> itself. Nuvo inked a pretty solid deal which on paper shows a non-
> royalty commitment of $125 million. The initial $25 million (agreement
> & approval bonuses) plus up to $100 million in milestone bonuses.
> Covidien could have easily bought Nuvo for that amount back in June. I
> seriously couldn't see a buyout even being considered until product
> sales total over a billion.

> On Nov 6, 2:08 pm, Medlow <med...@gmail.com> wrote:

> > I know it's been discussed that Covidien buy out Nuvo after approval
> > but I think with the shares trading where they are it's more likley.
> > Just using some simple #'s Shares are 410M (assuming the warrants go
> > through)  and in the debt of roughly 20M and cash 29M + 9M for
> > warrants totaling 38M + 2M is assests brings up to around 40M + or -.
> > So if Covidien put in an offer for 50 cents a share 205M + 20M (debt)
> > - 40M (cash + assets) = 185M to own Nuvo. If I was Covidien I would be
> > all over this, I didnt count in the 15M they just got for approval and
> > if reach the goals 100M, they invested 115M they could own Nuvo for
> > 70M more and would give them Pennsaid Plus and the WF10 drugs which
> > would be really cheap! Most people would want the share price to be
> > higher and so would I, at 75 cents a share it would cost them
> > additional 172M which is still reasonable.

> > These were just rough #'s but I think it's pretty sound and with out
> > knowing the actual agreement it's anybodys guess. I find it a little
> > suspect that the terms of the agreement still havent been released and
> > they only thing I think think of is there is a buyout clause somewhere
> > in it.

> > Anybody else thinking the same as me on this or am I out to lunch?

> > On Nov 6, 10:33 am, Rudee <rude...@gmail.com> wrote:

> > > I'm with you on that Adam.  I've previously locked in profits and I'm
> > > now long riding on the houses money.

> > > On Nov 6, 10:16 am, AdamJ <ajtimper...@gmail.com> wrote:

> > > > If I'd been in since February I would skim trade or take half off the
> > > > table. Really easy to sit on a free position for the long.

> > > > On Nov 6, 11:36 am, happy4days <happy4d...@gmail.com> wrote:

> > > > > In a half a year the product will be across America, pharmacies,
> > > > > doctors will have it too.  The pps will go up in time but people are
> > > > > selling because they wanted a quick profit!  I'm waiting for the low
> > > > > today and buying more soon!  I have been in since Febuary so what
> > > > > another six months to a year?  We will be rewared in a yearI
> > > > > Patience!  GTLA- Hide quoted text -

> > > - Show quoted text -- Hide quoted text -

> - Show quoted text -

> Adam I see some of your points and they make sense but...No track
> record in the US your right but lots of small pharma's get bought by
> bigger ones after approvals. Fact is neither of us know what the deal
> is right now there is always alot of variables in them not quite as
> cut and dry and you seem to make it so the whole lawsuit stuff and
> board members being fired is a bit of a stretch and I wouldnt expect
> them to do a bad deal would have to make sense for both parties. You
> called the deal solid?  how can you call it solid when you dont even
> know the #'s? Only thing really said is 100M milstone and in line with
> the industry. In line with the industry is a broad range it's not just
> a set % or anything like that.

> All I;m saying if they had some good clauses in the deal it's possible
> and would make sense given the forecast of future sales for the price

> On Nov 6, 1:09 pm, AdamJ <ajtimper...@gmail.com> wrote:

> > $175 million for one product with no track record in the US? Come on
> > get serious. If Covidien want to buy Nuvo it would have happened
> > instead of signing a deal and throwing away $25 million. Your
> > valuation of the company is based on money that the potential buyer
> > has already invested which just doesn't even make sense. That type of
> > deal would be a great way for the board and executives a Covidien to
> > lose their jobs and face a whack of lawsuits. Chances of a buyout are
> > slim to none. The main money is in the supply chain not in the
> > development.

> > The other reason I think why we won't see a buy out is the deal
> > itself. Nuvo inked a pretty solid deal which on paper shows a non-
> > royalty commitment of $125 million. The initial $25 million (agreement
> > & approval bonuses) plus up to $100 million in milestone bonuses.
> > Covidien could have easily bought Nuvo for that amount back in June. I
> > seriously couldn't see a buyout even being considered until product
> > sales total over a billion.

> > On Nov 6, 2:08 pm, Medlow <med...@gmail.com> wrote:

> > > I know it's been discussed that Covidien buy out Nuvo after approval
> > > but I think with the shares trading where they are it's more likley.
> > > Just using some simple #'s Shares are 410M (assuming the warrants go
> > > through)  and in the debt of roughly 20M and cash 29M + 9M for
> > > warrants totaling 38M + 2M is assests brings up to around 40M + or -.
> > > So if Covidien put in an offer for 50 cents a share 205M + 20M (debt)
> > > - 40M (cash + assets) = 185M to own Nuvo. If I was Covidien I would be
> > > all over this, I didnt count in the 15M they just got for approval and
> > > if reach the goals 100M, they invested 115M they could own Nuvo for
> > > 70M more and would give them Pennsaid Plus and the WF10 drugs which
> > > would be really cheap! Most people would want the share price to be
> > > higher and so would I, at 75 cents a share it would cost them
> > > additional 172M which is still reasonable.

> > > These were just rough #'s but I think it's pretty sound and with out
> > > knowing the actual agreement it's anybodys guess. I find it a little
> > > suspect that the terms of the agreement still havent been released and
> > > they only thing I think think of is there is a buyout clause somewhere
> > > in it.

> > > Anybody else thinking the same as me on this or am I out to lunch?

> > > On Nov 6, 10:33 am, Rudee <rude...@gmail.com> wrote:

> > > > I'm with you on that Adam.  I've previously locked in profits and I'm
> > > > now long riding on the houses money.

> > > > On Nov 6, 10:16 am, AdamJ <ajtimper...@gmail.com> wrote:

> > > > > If I'd been in since February I would skim trade or take half off the
> > > > > table. Really easy to sit on a free position for the long.

> > > > > On Nov 6, 11:36 am, happy4days <happy4d...@gmail.com> wrote:

> > > > > > In a half a year the product will be across America, pharmacies,
> > > > > > doctors will have it too.  The pps will go up in time but people are
> > > > > > selling because they wanted a quick profit!  I'm waiting for the low
> > > > > > today and buying more soon!  I have been in since Febuary so what
> > > > > > another six months to a year?  We will be rewared in a yearI
> > > > > > Patience!  GTLA- Hide quoted text -

> > > > - Show quoted text -- Hide quoted text -

> > - Show quoted text -

> So you are saying that NRI has to prove it's self in sales in US and
> then when sales are over a billion, then Covidien may considering
> buying NRI?  So instead of buying NRI now it wants to wait until NRI
> market cap is a billion (sales/revenue increase causes pps/mc to
> increase) before buyout?  In other words pay more for it later...makes
> perfect sense!

> On Nov 6, 3:09 pm, AdamJ <ajtimper...@gmail.com> wrote:

> > $175 million for one product with no track record in the US? Come on
> > get serious. If Covidien want to buy Nuvo it would have happened
> > instead of signing a deal and throwing away $25 million. Your
> > valuation of the company is based on money that the potential buyer
> > has already invested which just doesn't even make sense. That type of
> > deal would be a great way for the board and executives a Covidien to
> > lose their jobs and face a whack of lawsuits. Chances of a buyout are
> > slim to none. The main money is in the supply chain not in the
> > development.

> > The other reason I think why we won't see a buy out is the deal
> > itself. Nuvo inked a pretty solid deal which on paper shows a non-
> > royalty commitment of $125 million. The initial $25 million (agreement
> > & approval bonuses) plus up to $100 million in milestone bonuses.
> > Covidien could have easily bought Nuvo for that amount back in June. I
> > seriously couldn't see a buyout even being considered until product
> > sales total over a billion.

> > On Nov 6, 2:08 pm, Medlow <med...@gmail.com> wrote:

> > > I know it's been discussed that Covidien buy out Nuvo after approval
> > > but I think with the shares trading where they are it's more likley.
> > > Just using some simple #'s Shares are 410M (assuming the warrants go
> > > through)  and in the debt of roughly 20M and cash 29M + 9M for
> > > warrants totaling 38M + 2M is assests brings up to around 40M + or -.
> > > So if Covidien put in an offer for 50 cents a share 205M + 20M (debt)
> > > - 40M (cash + assets) = 185M to own Nuvo. If I was Covidien I would be
> > > all over this, I didnt count in the 15M they just got for approval and
> > > if reach the goals 100M, they invested 115M they could own Nuvo for
> > > 70M more and would give them Pennsaid Plus and the WF10 drugs which
> > > would be really cheap! Most people would want the share price to be
> > > higher and so would I, at 75 cents a share it would cost them
> > > additional 172M which is still reasonable.

> > > These were just rough #'s but I think it's pretty sound and with out
> > > knowing the actual agreement it's anybodys guess. I find it a little
> > > suspect that the terms of the agreement still havent been released and
> > > they only thing I think think of is there is a buyout clause somewhere
> > > in it.

> > > Anybody else thinking the same as me on this or am I out to lunch?

> > > On Nov 6, 10:33 am, Rudee <rude...@gmail.com> wrote:

> > > > I'm with you on that Adam.  I've previously locked in profits and I'm
> > > > now long riding on the houses money.

> > > > On Nov 6, 10:16 am, AdamJ <ajtimper...@gmail.com> wrote:

> > > > > If I'd been in since February I would skim trade or take half off the
> > > > > table. Really easy to sit on a free position for the long.

> > > > > On Nov 6, 11:36 am, happy4days <happy4d...@gmail.com> wrote:

> > > > > > In a half a year the product will be across America, pharmacies,
> > > > > > doctors will have it too.  The pps will go up in time but people are
> > > > > > selling because they wanted a quick profit!  I'm waiting for the low
> > > > > > today and buying more soon!  I have been in since Febuary so what
> > > > > > another six months to a year?  We will be rewared in a yearI
> > > > > > Patience!  GTLA- Hide quoted text -

> > > > - Show quoted text -- Hide quoted text -

> > - Show quoted text -

> Personally, I think a Covidien buyout is not going to happen anytime
> soon - if at all.    The 3 biggest movers to affect the future
> shareprice of NRI are earnings earnings earnings.   Once they
> penetrate the US market and the coffers start filling with cash, then
> we can perhaps bitch and complain about the share price, but until
> Pennsaid is on shelves in the US, I don't realistically expect any
> major moves to the upside in the near future, give or take a dime.

> On Nov 6, 1:36 pm, BoWing <gladyjun...@gmail.com> wrote:

> > So you are saying that NRI has to prove it's self in sales in US and
> > then when sales are over a billion, then Covidien may considering
> > buying NRI?  So instead of buying NRI now it wants to wait until NRI
> > market cap is a billion (sales/revenue increase causes pps/mc to
> > increase) before buyout?  In other words pay more for it later...makes
> > perfect sense!

> > On Nov 6, 3:09 pm, AdamJ <ajtimper...@gmail.com> wrote:

> > > $175 million for one product with no track record in the US? Come on
> > > get serious. If Covidien want to buy Nuvo it would have happened
> > > instead of signing a deal and throwing away $25 million. Your
> > > valuation of the company is based on money that the potential buyer
> > > has already invested which just doesn't even make sense. That type of
> > > deal would be a great way for the board and executives a Covidien to
> > > lose their jobs and face a whack of lawsuits. Chances of a buyout are
> > > slim to none. The main money is in the supply chain not in the
> > > development.

> > > The other reason I think why we won't see a buy out is the deal
> > > itself. Nuvo inked a pretty solid deal which on paper shows a non-
> > > royalty commitment of $125 million. The initial $25 million (agreement
> > > & approval bonuses) plus up to $100 million in milestone bonuses.
> > > Covidien could have easily bought Nuvo for that amount back in June. I
> > > seriously couldn't see a buyout even being considered until product
> > > sales total over a billion.

> > > On Nov 6, 2:08 pm, Medlow <med...@gmail.com> wrote:

> > > > I know it's been discussed that Covidien buy out Nuvo after approval
> > > > but I think with the shares trading where they are it's more likley.
> > > > Just using some simple #'s Shares are 410M (assuming the warrants go
> > > > through)  and in the debt of roughly 20M and cash 29M + 9M for
> > > > warrants totaling 38M + 2M is assests brings up to around 40M + or -.
> > > > So if Covidien put in an offer for 50 cents a share 205M + 20M (debt)
> > > > - 40M (cash + assets) = 185M to own Nuvo. If I was Covidien I would be
> > > > all over this, I didnt count in the 15M they just got for approval and
> > > > if reach the goals 100M, they invested 115M they could own Nuvo for
> > > > 70M more and would give them Pennsaid Plus and the WF10 drugs which
> > > > would be really cheap! Most people would want the share price to be
> > > > higher and so would I, at 75 cents a share it would cost them
> > > > additional 172M which is still reasonable.

> > > > These were just rough #'s but I think it's pretty sound and with out
> > > > knowing the actual agreement it's anybodys guess. I find it a little
> > > > suspect that the terms of the agreement still havent been released and
> > > > they only thing I think think of is there is a buyout clause somewhere
> > > > in it.

> > > > Anybody else thinking the same as me on this or am I out to lunch?

> > > > On Nov 6, 10:33 am, Rudee <rude...@gmail.com> wrote:

> > > > > I'm with you on that Adam.  I've previously locked in profits and I'm
> > > > > now long riding on the houses money.

> > > > > On Nov 6, 10:16 am, AdamJ <ajtimper...@gmail.com> wrote:

> > > > > > If I'd been in since February I would skim trade or take half off the
> > > > > > table. Really easy to sit on a free position for the long.

> > > > > > On Nov 6, 11:36 am, happy4days <happy4d...@gmail.com> wrote:

> > > > > > > In a half a year the product will be across America, pharmacies,
> > > > > > > doctors will have it too.  The pps will go up in time but people are
> > > > > > > selling because they wanted a quick profit!  I'm waiting for the low
> > > > > > > today and buying more soon!  I have been in since Febuary so what
> > > > > > > another six months to a year?  We will be rewared in a yearI
> > > > > > > Patience!  GTLA- Hide quoted text -

> > > > > - Show quoted text -- Hide quoted text -

> > > - Show quoted text -- Hide quoted text -

> - Show quoted text -

> Personally, I think a Covidien buyout is not going to happen anytime
> soon - if at all.    The 3 biggest movers to affect the future
> shareprice of NRI are earnings earnings earnings.   Once they
> penetrate the US market and the coffers start filling with cash, then
> we can perhaps bitch and complain about the share price, but until
> Pennsaid is on shelves in the US, I don't realistically expect any
> major moves to the upside in the near future, give or take a dime.

> On Nov 6, 1:36 pm, BoWing <gladyjun...@gmail.com> wrote:

> > So you are saying that NRI has to prove it's self in sales in US and
> > then when sales are over a billion, then Covidien may considering
> > buying NRI?  So instead of buying NRI now it wants to wait until NRI
> > market cap is a billion (sales/revenue increase causes pps/mc to
> > increase) before buyout?  In other words pay more for it later...makes
> > perfect sense!

> > On Nov 6, 3:09 pm, AdamJ <ajtimper...@gmail.com> wrote:

> > > $175 million for one product with no track record in the US? Come on
> > > get serious. If Covidien want to buy Nuvo it would have happened
> > > instead of signing a deal and throwing away $25 million. Your
> > > valuation of the company is based on money that the potential buyer
> > > has already invested which just doesn't even make sense. That type of
> > > deal would be a great way for the board and executives a Covidien to
> > > lose their jobs and face a whack of lawsuits. Chances of a buyout are
> > > slim to none. The main money is in the supply chain not in the
> > > development.

> > > The other reason I think why we won't see a buy out is the deal
> > > itself. Nuvo inked a pretty solid deal which on paper shows a non-
> > > royalty commitment of $125 million. The initial $25 million (agreement
> > > & approval bonuses) plus up to $100 million in milestone bonuses.
> > > Covidien could have easily bought Nuvo for that amount back in June. I
> > > seriously couldn't see a buyout even being considered until product
> > > sales total over a billion.

> > > On Nov 6, 2:08 pm, Medlow <med...@gmail.com> wrote:

> > > > I know it's been discussed that Covidien buy out Nuvo after approval
> > > > but I think with the shares trading where they are it's more likley.
> > > > Just using some simple #'s Shares are 410M (assuming the warrants go
> > > > through)  and in the debt of roughly 20M and cash 29M + 9M for
> > > > warrants totaling 38M + 2M is assests brings up to around 40M + or -.
> > > > So if Covidien put in an offer for 50 cents a share 205M + 20M (debt)
> > > > - 40M (cash + assets) = 185M to own Nuvo. If I was Covidien I would be
> > > > all over this, I didnt count in the 15M they just got for approval and
> > > > if reach the goals 100M, they invested 115M they could own Nuvo for
> > > > 70M more and would give them Pennsaid Plus and the WF10 drugs which
> > > > would be really cheap! Most people would want the share price to be
> > > > higher and so would I, at 75 cents a share it would cost them
> > > > additional 172M which is still reasonable.

> > > > These were just rough #'s but I think it's pretty sound and with out
> > > > knowing the actual agreement it's anybodys guess. I find it a little
> > > > suspect that the terms of the agreement still havent been released and
> > > > they only thing I think think of is there is a buyout clause somewhere
> > > > in it.

> > > > Anybody else thinking the same as me on this or am I out to lunch?

> > > > On Nov 6, 10:33 am, Rudee <rude...@gmail.com> wrote:

> > > > > I'm with you on that Adam.  I've previously locked in profits and I'm
> > > > > now long riding on the houses money.

> > > > > On Nov 6, 10:16 am, AdamJ <ajtimper...@gmail.com> wrote:

> > > > > > If I'd been in since February I would skim trade or take half off the
> > > > > > table. Really easy to sit on a free position for the long.

> > > > > > On Nov 6, 11:36 am, happy4days <happy4d...@gmail.com> wrote:

> > > > > > > In a half a year the product will be across America, pharmacies,
> > > > > > > doctors will have it too.  The pps will go up in time but people are
> > > > > > > selling because they wanted a quick profit!  I'm waiting for the low
> > > > > > > today and buying more soon!  I have been in since Febuary so what
> > > > > > > another six months to a year?  We will be rewared in a yearI
> > > > > > > Patience!  GTLA- Hide quoted text -

> > > > > - Show quoted text -- Hide quoted text -

> > > - Show quoted text -

> How quickly can they get it on the shelves?  Already being
> manufactured (check) so just need to ramp up production, labeling and
> instructions (check) - probably already sitting on someones laptop
> with version a (with ammendment) vs version b (without ammendment) for
> the last 3 months.  I'm sure Covidien marketing machine hasn't been
> sitting on their arses for the past 3 months wondering if approval is
> going to happen before getting the ball rolling.

> On Nov 6, 3:49 pm, Rudee <rude...@gmail.com> wrote:

> > Personally, I think a Covidien buyout is not going to happen anytime
> > soon - if at all.    The 3 biggest movers to affect the future
> > shareprice of NRI are earnings earnings earnings.   Once they
> > penetrate the US market and the coffers start filling with cash, then
> > we can perhaps bitch and complain about the share price, but until
> > Pennsaid is on shelves in the US, I don't realistically expect any
> > major moves to the upside in the near future, give or take a dime.

> > On Nov 6, 1:36 pm, BoWing <gladyjun...@gmail.com> wrote:

> > > So you are saying that NRI has to prove it's self in sales in US and
> > > then when sales are over a billion, then Covidien may considering
> > > buying NRI?  So instead of buying NRI now it wants to wait until NRI
> > > market cap is a billion (sales/revenue increase causes pps/mc to
> > > increase) before buyout?  In other words pay more for it later...makes
> > > perfect sense!

> > > On Nov 6, 3:09 pm, AdamJ <ajtimper...@gmail.com> wrote:

> > > > $175 million for one product with no track record in the US? Come on
> > > > get serious. If Covidien want to buy Nuvo it would have happened
> > > > instead of signing a deal and throwing away $25 million. Your
> > > > valuation of the company is based on money that the potential buyer
> > > > has already invested which just doesn't even make sense. That type of
> > > > deal would be a great way for the board and executives a Covidien to
> > > > lose their jobs and face a whack of lawsuits. Chances of a buyout are
> > > > slim to none. The main money is in the supply chain not in the
> > > > development.

> > > > The other reason I think why we won't see a buy out is the deal
> > > > itself. Nuvo inked a pretty solid deal which on paper shows a non-
> > > > royalty commitment of $125 million. The initial $25 million (agreement
> > > > & approval bonuses) plus up to $100 million in milestone bonuses.
> > > > Covidien could have easily bought Nuvo for that amount back in June. I
> > > > seriously couldn't see a buyout even being considered until product
> > > > sales total over a billion.

> > > > On Nov 6, 2:08 pm, Medlow <med...@gmail.com> wrote:

> > > > > I know it's been discussed that Covidien buy out Nuvo after approval
> > > > > but I think with the shares trading where they are it's more likley.
> > > > > Just using some simple #'s Shares are 410M (assuming the warrants go
> > > > > through)  and in the debt of roughly 20M and cash 29M + 9M for
> > > > > warrants totaling 38M + 2M is assests brings up to around 40M + or -.
> > > > > So if Covidien put in an offer for 50 cents a share 205M + 20M (debt)
> > > > > - 40M (cash + assets) = 185M to own Nuvo. If I was Covidien I would be
> > > > > all over this, I didnt count in the 15M they just got for approval and
> > > > > if reach the goals 100M, they invested 115M they could own Nuvo for
> > > > > 70M more and would give them Pennsaid Plus and the WF10 drugs which
> > > > > would be really cheap! Most people would want the share price to be
> > > > > higher and so would I, at 75 cents a share it would cost them
> > > > > additional 172M which is still reasonable.

> > > > > These were just rough #'s but I think it's pretty sound and with out
> > > > > knowing the actual agreement it's anybodys guess. I find it a little
> > > > > suspect that the terms of the agreement still havent been released and
> > > > > they only thing I think think of is there is a buyout clause somewhere
> > > > > in it.

> > > > > Anybody else thinking the same as me on this or am I out to lunch?

> > > > > On Nov 6, 10:33 am, Rudee <rude...@gmail.com> wrote:

> > > > > > I'm with you on that Adam.  I've previously locked in profits and I'm
> > > > > > now long riding on the houses money.

> > > > > > On Nov 6, 10:16 am, AdamJ <ajtimper...@gmail.com> wrote:

> > > > > > > If I'd been in since February I would skim trade or take half off the
> > > > > > > table. Really easy to sit on a free position for the long.

> > > > > > > On Nov 6, 11:36 am, happy4days <happy4d...@gmail.com> wrote:

> > > > > > > > In a half a year the product will be across America, pharmacies,
> > > > > > > > doctors will have it too.  The pps will go up in time but people are
> > > > > > > > selling because they wanted a quick profit!  I'm waiting for the low
> > > > > > > > today and buying more soon!  I have been in since Febuary so what
> > > > > > > > another six months to a year?  We will be rewared in a yearI
> > > > > > > > Patience!  GTLA- Hide quoted text -

> > > > > > - Show quoted text -- Hide quoted text -

> > > > - Show quoted text -- Hide quoted text -

> > - Show quoted text -- Hide quoted text -

> - Show quoted text -

> Rudee I'm more bitching at dumbass healthcare stock traders who buy
> HEB at $4 (it's still trading above a dollar now, 5 months after their
> supposed decision date) and then sell Nuvo at pre-approval prices
> AFTER it receives the biggest news in their company's history.

> On Nov 6, 3:49 pm, Rudee <rude...@gmail.com> wrote:

> > Personally, I think a Covidien buyout is not going to happen anytime
> > soon - if at all.    The 3 biggest movers to affect the future
> > shareprice of NRI are earnings earnings earnings.   Once they
> > penetrate the US market and the coffers start filling with cash, then
> > we can perhaps bitch and complain about the share price, but until
> > Pennsaid is on shelves in the US, I don't realistically expect any
> > major moves to the upside in the near future, give or take a dime.

> > On Nov 6, 1:36 pm, BoWing <gladyjun...@gmail.com> wrote:

> > > So you are saying that NRI has to prove it's self in sales in US and
> > > then when sales are over a billion, then Covidien may considering
> > > buying NRI?  So instead of buying NRI now it wants to wait until NRI
> > > market cap is a billion (sales/revenue increase causes pps/mc to
> > > increase) before buyout?  In other words pay more for it later...makes
> > > perfect sense!

> > > On Nov 6, 3:09 pm, AdamJ <ajtimper...@gmail.com> wrote:

> > > > $175 million for one product with no track record in the US? Come on
> > > > get serious. If Covidien want to buy Nuvo it would have happened
> > > > instead of signing a deal and throwing away $25 million. Your
> > > > valuation of the company is based on money that the potential buyer
> > > > has already invested which just doesn't even make sense. That type of
> > > > deal would be a great way for the board and executives a Covidien to
> > > > lose their jobs and face a whack of lawsuits. Chances of a buyout are
> > > > slim to none. The main money is in the supply chain not in the
> > > > development.

> > > > The other reason I think why we won't see a buy out is the deal
> > > > itself. Nuvo inked a pretty solid deal which on paper shows a non-
> > > > royalty commitment of $125 million. The initial $25 million (agreement
> > > > & approval bonuses) plus up to $100 million in milestone bonuses.
> > > > Covidien could have easily bought Nuvo for that amount back in June. I
> > > > seriously couldn't see a buyout even being considered until product
> > > > sales total over a billion.

> > > > On Nov 6, 2:08 pm, Medlow <med...@gmail.com> wrote:

> > > > > I know it's been discussed that Covidien buy out Nuvo after approval
> > > > > but I think with the shares trading where they are it's more likley.
> > > > > Just using some simple #'s Shares are 410M (assuming the warrants go
> > > > > through)  and in the debt of roughly 20M and cash 29M + 9M for
> > > > > warrants totaling 38M + 2M is assests brings up to around 40M + or -.
> > > > > So if Covidien put in an offer for 50 cents a share 205M + 20M (debt)
> > > > > - 40M (cash + assets) = 185M to own Nuvo. If I was Covidien I would be
> > > > > all over this, I didnt count in the 15M they just got for approval and
> > > > > if reach the goals 100M, they invested 115M they could own Nuvo for
> > > > > 70M more and would give them Pennsaid Plus and the WF10 drugs which
> > > > > would be really cheap! Most people would want the share price to be
> > > > > higher and so would I, at 75 cents a share it would cost them
> > > > > additional 172M which is still reasonable.

> > > > > These were just rough #'s but I think it's pretty sound and with out
> > > > > knowing the actual agreement it's anybodys guess. I find it a little
> > > > > suspect that the terms of the agreement still havent been released and
> > > > > they only thing I think think of is there is a buyout clause somewhere
> > > > > in it.

> > > > > Anybody else thinking the same as me on this or am I out to lunch?

> > > > > On Nov 6, 10:33 am, Rudee <rude...@gmail.com> wrote:

> > > > > > I'm with you on that Adam.  I've previously locked in profits and I'm
> > > > > > now long riding on the houses money.

> > > > > > On Nov 6, 10:16 am, AdamJ <ajtimper...@gmail.com> wrote:

> > > > > > > If I'd been in since February I would skim trade or take half off the
> > > > > > > table. Really easy to sit on a free position for the long.

> > > > > > > On Nov 6, 11:36 am, happy4days <happy4d...@gmail.com> wrote:

> > > > > > > > In a half a year the product will be across America, pharmacies,
> > > > > > > > doctors will have it too.  The pps will go up in time but people are
> > > > > > > > selling because they wanted a quick profit!  I'm waiting for the low
> > > > > > > > today and buying more soon!  I have been in since Febuary so what
> > > > > > > > another six months to a year?  We will be rewared in a yearI
> > > > > > > > Patience!  GTLA- Hide quoted text -

> > > > > > - Show quoted text -- Hide quoted text -

> > > > - Show quoted text -

> Yeah, that HEB fiasco is another thing..... What a mess for investors
> that's been.

> On Nov 6, 2:11 pm, Vinny <vancemend...@gmail.com> wrote:

> > Rudee I'm more bitching at dumbass healthcare stock traders who buy
> > HEB at $4 (it's still trading above a dollar now, 5 months after their
> > supposed decision date) and then sell Nuvo at pre-approval prices
> > AFTER it receives the biggest news in their company's history.

> > On Nov 6, 3:49 pm, Rudee <rude...@gmail.com> wrote:

> > > Personally, I think a Covidien buyout is not going to happen anytime
> > > soon - if at all.    The 3 biggest movers to affect the future
> > > shareprice of NRI are earnings earnings earnings.   Once they
> > > penetrate the US market and the coffers start filling with cash, then
> > > we can perhaps bitch and complain about the share price, but until
> > > Pennsaid is on shelves in the US, I don't realistically expect any
> > > major moves to the upside in the near future, give or take a dime.

> > > On Nov 6, 1:36 pm, BoWing <gladyjun...@gmail.com> wrote:

> > > > So you are saying that NRI has to prove it's self in sales in US and
> > > > then when sales are over a billion, then Covidien may considering
> > > > buying NRI?  So instead of buying NRI now it wants to wait until NRI
> > > > market cap is a billion (sales/revenue increase causes pps/mc to
> > > > increase) before buyout?  In other words pay more for it later...makes
> > > > perfect sense!

> > > > On Nov 6, 3:09 pm, AdamJ <ajtimper...@gmail.com> wrote:

> > > > > $175 million for one product with no track record in the US? Come on
> > > > > get serious. If Covidien want to buy Nuvo it would have happened
> > > > > instead of signing a deal and throwing away $25 million. Your
> > > > > valuation of the company is based on money that the potential buyer
> > > > > has already invested which just doesn't even make sense. That type of
> > > > > deal would be a great way for the board and executives a Covidien to
> > > > > lose their jobs and face a whack of lawsuits. Chances of a buyout are
> > > > > slim to none. The main money is in the supply chain not in the
> > > > > development.

> > > > > The other reason I think why we won't see a buy out is the deal
> > > > > itself. Nuvo inked a pretty solid deal which on paper shows a non-
> > > > > royalty commitment of $125 million. The initial $25 million (agreement
> > > > > & approval bonuses) plus up to $100 million in milestone bonuses.
> > > > > Covidien could have easily bought Nuvo for that amount back in June. I
> > > > > seriously couldn't see a buyout even being considered until product
> > > > > sales total over a billion.

> > > > > On Nov 6, 2:08 pm, Medlow <med...@gmail.com> wrote:

> > > > > > I know it's been discussed that Covidien buy out Nuvo after approval
> > > > > > but I think with the shares trading where they are it's more likley.
> > > > > > Just using some simple #'s Shares are 410M (assuming the warrants go
> > > > > > through)  and in the debt of roughly 20M and cash 29M + 9M for
> > > > > > warrants totaling 38M + 2M is assests brings up to around 40M + or -.
> > > > > > So if Covidien put in an offer for 50 cents a share 205M + 20M (debt)
> > > > > > - 40M (cash + assets) = 185M to own Nuvo. If I was Covidien I would be
> > > > > > all over this, I didnt count in the 15M they just got for approval and
> > > > > > if reach the goals 100M, they invested 115M they could own Nuvo for
> > > > > > 70M more and would give them Pennsaid Plus and the WF10 drugs which
> > > > > > would be really cheap! Most people would want the share price to be
> > > > > > higher and so would I, at 75 cents a share it would cost them
> > > > > > additional 172M which is still reasonable.

> > > > > > These were just rough #'s but I think it's pretty sound and with out
> > > > > > knowing the actual agreement it's anybodys guess. I find it a little
> > > > > > suspect that the terms of the agreement still havent been released and
> > > > > > they only thing I think think of is there is a buyout clause somewhere
> > > > > > in it.

> > > > > > Anybody else thinking the same as me on this or am I out to lunch?

> > > > > > On Nov 6, 10:33 am, Rudee <rude...@gmail.com> wrote:

> > > > > > > I'm with you on that Adam.  I've previously locked in profits and I'm
> > > > > > > now long riding on the houses money.

> > > > > > > On Nov 6, 10:16 am, AdamJ <ajtimper...@gmail.com> wrote:

> > > > > > > > If I'd been in since February I would skim trade or take half off the
> > > > > > > > table. Really easy to sit on a free position for the long.

> > > > > > > > On Nov 6, 11:36 am, happy4days <happy4d...@gmail.com> wrote:

> > > > > > > > > In a half a year the product will be across America, pharmacies,
> > > > > > > > > doctors will have it too.  The pps will go up in time but people are
> > > > > > > > > selling because they wanted a quick profit!  I'm waiting for the low
> > > > > > > > > today and buying more soon!  I have been in since Febuary so what
> > > > > > > > > another six months to a year?  We will be rewared in a yearI
> > > > > > > > > Patience!  GTLA- Hide quoted text -

> > > > > > > - Show quoted text -- Hide quoted text -

> > > > > - Show quoted text -